Nectin Therapeutics
https://www.nectintx.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nectin Therapeutics
Israeli Biopharma Leaders Focus On Near-Term Targets
Biopharma executives in Israel rely on their global footprint and a 'culture of resilience'.
Finance Watch: $1.32bn In New Biopharma VC Financings As Year-End Approaches
Private Company Edition: In recent weeks, 19 companies disclosed venture capital funding of $20m or more, including FogPharma with a $178m series D round and Apogee’s $169m launch. Also, Avalon BioVentures spun out of Avalon Ventures with a $135m fund.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
- Other Names / Subsidiaries
-
- Nectin Therapeutic Inc
- Nectin Therapeutics Ltd
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice